spacer
spacer

PDBsum entry 1pw3

Go to PDB code: 
protein metals links
Immune system PDB id
1pw3

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
111 a.a. *
Metals
_CD ×4
Waters ×115
* Residue conservation analysis
PDB id:
1pw3
Name: Immune system
Title: Crystal structure of jtor68s
Structure: Immunoglobulin lambda chain variable region. Chain: a, b. Synonym: jto. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: jto. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
1.90Å     R-factor:   0.220     R-free:   0.233
Authors: C.Dealwis,V.Gupta,M.Wilkerson
Key ref: J.S.Wall et al. (2004). Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. J Mol Recognit, 17, 323-331. PubMed id: 15227639
Date:
30-Jun-03     Release date:   17-Aug-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q96JD1  (Q96JD1_HUMAN) -  Amyloid lambda 6 light chain variable region PIP (Fragment) from Homo sapiens
Seq:
Struc:
112 a.a.
111 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 11 residue positions (black crosses)

 

 
J Mol Recognit 17:323-331 (2004)
PubMed id: 15227639  
 
 
Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
J.S.Wall, V.Gupta, M.Wilkerson, M.Schell, R.Loris, P.Adams, A.Solomon, F.Stevens, C.Dealwis.
 
  ABSTRACT  
 
Primary (AL) amyloidosis results from the pathologic deposition of monoclonal light chains as amyloid fibrils. Studies of recombinant-derived variable region (VL) fragments of these proteins have shown an inverse relationship between thermodynamic stability and fibrillogenic potential. Further, ionic interactions within the VL domain were predicted to influence the kinetics of light chain fibrillogenicity, as evidenced from our analyses of a relatively stable Vlambda6 protein (Jto) with a long range electrostatic interaction between Asp and Arg side chains at position 29 and 68, respectively, and an unstable, highly fibrillogenic Vlambda6 protein (Wil) that had neutral amino acids at these locations. To test this hypothesis, we have generated two Jto-related mutants designed to disrupt the interaction between Asp 29 and Arg 68 (JtoD29A and JtoR68S). Although the thermodynamic stabilities of unfolding for these two molecules were identical, they exhibited very different kinetics of fibril formation: the rate of JtoD29A fibrillogenesis was slow and comparable to the parent molecule, whereas that of JtoR68S was significantly faster. High-resolution X-ray diffraction analyses of crystals prepared from the two mutants having the same space group and unit cell dimensions revealed no significant main-chain conformational changes. However, several notable side-chain alterations were observed in JtoR68S, as compared with JtoD29A, that resulted in the solvent exposure of a greater hydrophobic surface and modifications in the electrostatic potential surface. We posit that these differences contributed to the enhanced fibrillogenic potential of the Arg 68 mutant, since both Jto mutants lacked the intrachain ionic interaction and were equivalently unstable. The information gleaned from our studies has provided insight into structural parameters that in addition to overall thermodynamic stability, contribute to the fibril forming propensity of immunoglobulin light chains.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19361523 E.G.Randles, J.R.Thompson, D.J.Martin, and M.Ramirez-Alvarado (2009).
Structural alterations within native amyloidogenic immunoglobulin light chains.
  J Mol Biol, 389, 199-210.
PDB codes: 3dvf 3dvi
19617578 R.L.Comenzo (2009).
How I treat amyloidosis.
  Blood, 114, 3147-3157.  
18567838 B.K.Arendt, M.Ramirez-Alvarado, L.A.Sikkink, J.J.Keats, G.J.Ahmann, A.Dispenzieri, R.Fonseca, R.P.Ketterling, R.A.Knudson, E.M.Mulvihill, R.C.Tschumper, X.Wu, S.R.Zeldenrust, and D.F.Jelinek (2008).
Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.
  Blood, 112, 1931-1941.  
18400753 E.M.Baden, B.A.Owen, F.C.Peterson, B.F.Volkman, M.Ramirez-Alvarado, and J.R.Thompson (2008).
Altered dimer interface decreases stability in an amyloidogenic protein.
  J Biol Chem, 283, 15853-15860.
PDB codes: 2q1e 2q20
18768467 E.M.Baden, E.G.Randles, A.K.Aboagye, J.R.Thompson, and M.Ramirez-Alvarado (2008).
Structural insights into the role of mutations in amyloidogenesis.
  J Biol Chem, 283, 30950-30956.
PDB codes: 3cdc 3cdf 3cdy
18260098 L.del Pozo Yauner, E.Ortiz, R.Sánchez, R.Sánchez-López, L.Güereca, C.L.Murphy, A.Allen, J.S.Wall, D.A.Fernández-Velasco, A.Solomon, and B.Becerril (2008).
Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains.
  Proteins, 72, 684-692.  
17260953 B.O'Nuallain, A.Allen, S.J.Kennel, D.T.Weiss, A.Solomon, and J.S.Wall (2007).
Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.
  Biochemistry, 46, 1240-1247.  
17587239 J.Teng, E.A.Turbat-Herrera, and G.A.Herrera (2007).
Role of translational research advancing the understanding of the pathogenesis of light chain-mediated glomerulopathies.
  Pathol Int, 57, 398-412.  
15641119 M.Król, I.Roterman, B.Piekarska, L.Konieczny, J.Rybarska, B.Stopa, P.Spólnik, and E.Szneler (2005).
An approach to understand the complexation of supramolecular dye Congo red with immunoglobulin L chain lambda.
  Biopolymers, 77, 155-162.  
15687834 P.W.Sanders (2005).
Management of paraproteinemic renal disease.
  Curr Opin Nephrol Hypertens, 14, 97.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer